Plexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack

Plexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack pose a serious risk to your health and should not be taken.

The Therapeutic Goods Administration (TGA) has tested Plexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack capsules and found that:

• They contain the undeclared banned chemical 1,3-dimethylamylamine (DMAA)
• Consumers are advised that DMAA is listed in Appendix C of the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). Substances within Appendix C are of such danger to health as to warrant prohibition of sale, supply and use.
• Risks associated with its use include high blood pressure, psychiatric disorders, bleeding in the brain and stroke.

Further information about DMAA can be found on the TGA website:

•  The TGA decision to ban DMAA

The supply of Plexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack is illegal.

Plexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.

TGA investigations have shown that a number of people in Australia have bought the product online.

Information for consumers

• Stop taking Plexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack and take any remaining capsules to your local pharmacy for safe disposal.
• If you have any concerns arising from your use of this product, consult your health care practitioner.

Action the TGA is taking

The TGA is working with Australian Customs and Border Protection Services (Customs) to help stop future shipments of Plexus Slim Accelerator capsules and Plexus Slim Accelerator 3 Day Trial pack from entering Australia.

The TGA is advising consumers to exercise extreme caution when purchasing medicines from unknown overseas Internet sites. Products purchased over the Internet:

• may contain undisclosed and potentially harmful ingredients
• may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia.

Report counterfeit medicines and medical devices

If you are worried about counterfeit medicines or medical devices, and want to report an issue, you can report the matter to the TGA:

Phone:	1800 020 653
Online:	Report a perceived breach of the Therapeutic Goods Act or questionable practices relating to therapeutic products
Email:	info@tga.gov.au